We are live on ! Find out more
HRTX icon

Heron Therapeutics
HRTX

99 hedge funds and large institutions have $690M invested in Heron Therapeutics in 2016 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 34 increasing their positions, 30 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

151% more call options, than puts

Call options by funds: $21.1M | Put options by funds: $8.42M

134.39% more ownership

Funds ownership: 0% → 134.39% (+134%)

80% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 10

13% more repeat investments, than reductions

Existing positions increased: 34 | Existing positions reduced: 30

9% more funds holding

Funds holding: 91 → 99 (+8)

0% more funds holding in top 10

Funds holding in top 10: 6 → 6 (0)

22% less capital invested

Capital invested by funds: $881M → $690M (-$191M)

Holders
99
Holders Change
+8
Holders Change %
+8.79%
% of All Funds
2.48%
Holding in Top 10
6
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.15%
New
18
Increased
34
Reduced
30
Closed
10
Calls
$21.1M
Puts
$8.42M
Net Calls
+$12.7M
Net Calls Change
+$7.51M

Top Buyers

1
BC
Broadfin Capital
New York
+$16.5M
2
HCMT
Highland Capital Management (Texas)
Texas
+$14.3M
3
JHIU
Janus Henderson Investors US
Colorado
+$8.5M
4
Alyeska Investment Group
Alyeska Investment Group
Illinois
+$5.13M
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$5.04M

Top Sellers

1
Invesco
Invesco
Georgia
-$34.3M
2
PHS
PFM Health Sciences
California
-$10.3M
3
BBA
Baker Bros. Advisors
New York
-$7.43M
4
RI
RTW Investments
New York
-$6.66M
5
Asset Management One
Asset Management One
Japan
-$4.69M
Name Holding Trade Value Shares
Change 		Change in
Stake
Deutsche Bank
26
Deutsche Bank
Germany
$3.35M +$2.47M +157,445 +161%
EAM
27
Eventide Asset Management
Massachusetts
$2.95M +$3.53M +225,000 New
Citigroup
28
Citigroup
New York
$2.81M +$3.21M +204,593 +2,048%
Citadel Advisors
29
Citadel Advisors
Florida
$2.31M +$2.77M +176,733 New
Morgan Stanley
30
Morgan Stanley
New York
$2.05M +$1.14M +72,859 +87%
HT
31
HAP Trading
New York
$2.02M +$2.42M +154,035 New
Bank of New York Mellon
32
Bank of New York Mellon
New York
$1.97M +$2.86K +182 +0.1%
BIM
33
BlackRock Investment Management
Delaware
$1.61M -$8.8K -561 -0.5%
Charles Schwab
34
Charles Schwab
California
$1.58M -$93.4K -5,950 -5%
GC
35
Guggenheim Capital
Illinois
$1.34M +$147K +9,339 +10%
LOAMU
36
Lombard Odier Asset Management (USA)
New York
$1.31M -$1.18M -75,000 -43%
Allianz Asset Management
37
Allianz Asset Management
Germany
$1.23M -$1.17M -74,441 -44%
TCIM
38
TIAA CREF Investment Management
New York
$1.2M -$70.1K -4,469 -5%
JP Morgan Chase
39
JP Morgan Chase
New York
$884K +$37.1K +2,363 +4%
AGC
40
Alden Global Capital
Florida
$864K +$1.03M +65,935 New
California State Teachers Retirement System (CalSTRS)
41
California State Teachers Retirement System (CalSTRS)
California
$858K -$28.2K -1,800 -3%
California Public Employees Retirement System
42
California Public Employees Retirement System
California
$816K – – –
GH
43
GAM Holding
Switzerland
$774K – – –
TA
44
Teachers Advisors
New York
$758K +$30.2K +1,924 +3%
CG
45
Cutler Group
California
$739K +$512K +32,623 +137%
Swiss National Bank
46
Swiss National Bank
Switzerland
$680K – – –
Bank of America
47
Bank of America
North Carolina
$675K +$107K +6,848 +15%
AllianceBernstein
48
AllianceBernstein
Tennessee
$638K – – –
PIM
49
Partner Investment Management
California
$618K -$143K -9,097 -16%
UBS Group
50
UBS Group
Switzerland
$585K +$560K +35,686 +398%
1
2
3 4 5

HRTX Hedge Fund Activity: Q4 2016 in Review

99 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Heron Therapeutics (HRTX) for Q4 2016, worth a combined $690M — down 22% from $881M a quarter earlier.

Buyers outnumbered sellers: 18 funds opened new HRTX positions and 10 closed out — a net gain of 8 holders — while 34 added to existing stakes and 30 trimmed.

The largest buyer was Broadfin Capital, adding an estimated $16.5M. The largest seller was Invesco, cutting an estimated $34.3M.

  • 99 institutional investors held Heron Therapeutics (HRTX) as of Q4 2016, up from 91 in Q3 2016.
  • Funds reported $690M of Heron Therapeutics stock for Q4 2016, down 22% quarter-over-quarter.
  • 18 funds opened new Heron Therapeutics positions in Q4 2016 and 10 closed out, a net change of +8 holders.
  • The largest Heron Therapeutics buyer in Q4 2016 was Broadfin Capital, an estimated $16.5M added.
  • The largest Heron Therapeutics seller in Q4 2016 was Invesco, an estimated $34.3M sold.

Based on aggregated 13F filings for Q4 2016.